Related Experiment Video

Updated: Sep 26, 2026

Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates
13:55

Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates

Published on: January 27, 2019

Role of vasoactive mediators in the pathogenesis of Chagas' disease

Shankar Mukherjee1, Huan Huang, Louis M Weiss

  • 1Department of Pathology, Albert Einstein College of Medicine, Bronx, New York 10461, USA.

Frontiers in Bioscience : a Journal and Virtual Library
|April 18, 2003
PubMed

Insights

Chagas disease cardiomyopathy stems from vascular issues linked to Trypanosoma cruzi. Disruptions in endothelin-1 and kinins

Area of Science:

  • Cardiovascular Science
  • Infectious Diseases
  • Vascular Biology

Background:

  • Chagas' disease, caused by Trypanosoma cruzi, leads to cardiomyopathy.
  • Vascular dysfunction is a key feature of Chagas' disease pathology.
  • Vasoactive peptides play critical roles in cardiovascular homeostasis.

Purpose of the Study:

  • To review the vascular pathogenesis of Chagas' disease.
  • To explore the role of endothelin-1 and kinins in T. cruzi-induced cardiomyopathy.
  • To identify potential therapeutic targets for ameliorating heart pathology.

Main Methods:

  • Review of recent scientific literature.
  • Analysis of molecular mechanisms of vascular dysfunction.
  • Focus on peptidergic mediators in Trypanosoma cruzi infection.

Main Results:

  • T. cruzi infection is associated with altered activity of endothelin-1 (vasoconstrictor).
  • T. cruzi infection is linked to altered activity of kinins (vasodilators/pro-inflammatory).
  • These alterations contribute to disturbances in vascular homeostasis.

Conclusions:

  • Dysregulation of endothelin-1 and kinins is implicated in Chagas' disease cardiomyopathy.
  • Understanding these vascular mechanisms offers therapeutic intervention opportunities.
  • Targeting vascular pathways may help ameliorate heart pathology in Chagas' disease.

More Related Videos

Demystifying In Vivo Bioluminescence Imaging of a Chagas Disease Mouse Model for Drug Efficacy Studies07:59

Demystifying In Vivo Bioluminescence Imaging of a Chagas Disease Mouse Model for Drug Efficacy Studies

Published on: May 31, 2024

Parasite Induced Genetically Driven Autoimmune Chagas Heart Disease in the Chicken Model09:23

Parasite Induced Genetically Driven Autoimmune Chagas Heart Disease in the Chicken Model

Published on: July 29, 2012

Related Concept Videos

American Trypanosomiasis01:22

American Trypanosomiasis

Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...